Assessment of anilofos-induced mutagenicity in bone marrow and germ cells of Swiss albino mice.


Journal

Toxicology and industrial health
ISSN: 1477-0393
Titre abrégé: Toxicol Ind Health
Pays: England
ID NLM: 8602702

Informations de publication

Date de publication:
Feb 2020
Historique:
entrez: 14 4 2020
pubmed: 14 4 2020
medline: 20 2 2021
Statut: ppublish

Résumé

Anilofos is an organophosphate compound and is used extensively as a preemergence and early postemergence herbicide for the management of sedges, annual grasses, and some broad-leaved weeds in rice fields. The present study was aimed to assess the mutagenic potential of anilofos after sub-chronic exposure in Swiss albino mice. For this, a combined approach employing micronucleus (MN), chromosomal aberration (CA) studies and sperm-head abnormalities (SHAs) was used. Three dose levels of 1%, 2%, and 4% of maximum tolerated dose (MTD) (235 mg/kg b.wt.), that is, 2.35, 4.7 and 9.4 mg/kg b.wt., respectively, were administered orally daily for 90 days. A higher incidence of micronucleated erythrocytes (polychromatic erythrocytes + normochromatic erythrocytes), significant increase in CA frequency, and significant decrease in the ratio of polychromatic/normochromatic erythrocytes (P/N) ratio were observed at the 4.7 and 9.4 mg/kg b.wt. dose levels. A significant increase in SHA was observed in all treatment groups (2.35, 4.7, and 9.4 mg/kg b.wt.) from the control group. In conclusion, anilofos exposure of 2% and 4% of MTD caused a higher rate of micronucleated erythrocytes, increased frequency of CA, increase in SHA, and lower P/N ratio, and pesticide exposure of 1% of MTD only resulted in higher SHAs. Thus, anilofos was found to have mutagenic potential in mice when administered daily orally at dose rate of 4.7 and 9.4 mg/kg b.wt. for 90 days.

Identifiants

pubmed: 32279653
doi: 10.1177/0748233720913757
doi:

Substances chimiques

Herbicides 0
Mutagens 0
Organophosphorus Compounds 0
anilofos 71W48U40S6

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

110-118

Auteurs

Preeti Bagri (P)

Department of Veterinary Pharmacology and Toxicology, College of Veterinary Sciences, Lala Lajpat Rai University of Veterinary and Animal Sciences, Hisar, Haryana, India.

Vinod Kumar (V)

Department of Veterinary Pharmacology and Toxicology, College of Veterinary Sciences, Lala Lajpat Rai University of Veterinary and Animal Sciences, Hisar, Haryana, India.

Articles similaires

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male
Humans Meals Time Factors Female Adult

Classifications MeSH